Factor B and C4b2a Autoantibodies in C3 Glomerulopathy

Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2019.00668
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

C3 Glomerulopathy

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2017English

An Engineered Complement Factor H Construct for Treatment of C3 Glomerulopathy

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2018English

Membranoproliferative Glomerulonephritis and C3 Glomerulopathy: Resolving the Confusion

Yearbook of Pathology and Laboratory Medicine
2013English

Efficacy of Targeted Complement Inhibition in Experimental C3 Glomerulopathy

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2015English

Glomerular C3 Deposition Is an Independent Risk Factor for Allograft Failure in Kidney Transplant Recipients With Transplant Glomerulopathy

Kidney International Reports
Nephrology
2019English

Glomerular Complement Factor H Related Protein 5 (FHR5) Is Highly Prevalent in C3 Glomerulopathy and Associated With Renal Impairment

Kidney International Reports
Nephrology
2019English

Effectiveness of Cyclosporine in a 10-Year-Old Girl With C3 Glomerulopathy

Childhood Kidney Diseases
2017English

Both Monoclonal and Polyclonal Immunoglobulin Contingents Mediate Complement Activation in Monoclonal Gammopathy Associated-C3 Glomerulopathy

Frontiers in Immunology
AllergyImmunology
2018English

A Novel CFHR5 Fusion Protein Causes C3 Glomerulopathy in a Family Without Cypriot Ancestry

Kidney International
Nephrology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy